Avai Bio (AVAI) Debt to Equity (2018 - 2023)
Avai Bio's Debt to Equity history spans 5 years, with the latest figure at -$0.07 for Q4 2023.
- For Q4 2023, Debt to Equity fell 76.02% year-over-year to -$0.07; the TTM value through Dec 2023 reached -$0.07, down 76.02%, while the annual FY2023 figure was -$0.31, N/A changed from the prior year.
- Debt to Equity for Q4 2023 was -$0.07 at Avai Bio, up from -$0.1 in the prior quarter.
- Across five years, Debt to Equity topped out at $2.84 in Q3 2020 and bottomed at -$1.53 in Q3 2019.
- The 4-year median for Debt to Equity is -$0.09 (2020), against an average of -$0.1.
- The largest annual shift saw Debt to Equity skyrocketed 285.79% in 2020 before it crashed 766.98% in 2023.
- A 4-year view of Debt to Equity shows it stood at -$1.53 in 2019, then skyrocketed by 94.29% to -$0.09 in 2020, then skyrocketed by 53.97% to -$0.04 in 2022, then tumbled by 76.02% to -$0.07 in 2023.
- Per Business Quant, the three most recent readings for AVAI's Debt to Equity are -$0.07 (Q4 2023), -$0.1 (Q3 2023), and -$0.1 (Q2 2023).